Riverwood Healthcare Center will not offer monoclonal antibodies treatment for COVID-19 patients at this time due to staffing concerns.
“We’ve been offering the monoclonal antibodies infusion treatment for the past year, but with a large increase in the number of referrals of Covid patients this fall, we no longer have enough specially trained nursing staff to provide this service,” said Dr. David Taylor, Riverwood chief medical officer. “We will refer any patients in need of this treatment to other area health care centers that offer it.”
Monoclonal antibodies are given through an IV to keep COVID-19 symptoms from getting worse. This treatment can be effective at decreasing hospitalization rates and progression to severe disease and death for patients with mild to moderate COVID-19.
